1 articles with this tag
OpenAI hit $25B ARR in early 2026 while Helion secured fusion licences at a $15.5B valuation. A company-by-company breakdown of Sam Altman's four active ventures: OpenAI, Helion Energy, World ID, and Retro Biosciences.
